BIO-PATH HOLDINGS 8-K: Shareholder Vote Matters Reported

TL;DR

**BPTH just filed an 8-K about a shareholder vote, signaling potential big changes ahead.**

AI Summary

BIO-PATH HOLDINGS, INC. (BPTH) filed an 8-K on February 2, 2024, reporting an event that occurred on January 30, 2024, related to the submission of matters to a vote of security holders. This filing indicates that the company's common stock, with a par value of $0.001 per share, is registered on The Nasdaq Capital Market under the trading symbol BPTH. For investors, this matters because it signals that significant corporate actions requiring shareholder approval are underway or have recently concluded, which could impact the company's future direction and stock value.

Why It Matters

This filing indicates that shareholders have voted on or will vote on important company matters, which could lead to changes in corporate governance, capital structure, or strategic direction. Such changes can directly influence the stock's performance and the company's long-term prospects.

Risk Assessment

Risk Level: medium — The filing itself is administrative, but the underlying shareholder vote could involve high-impact decisions, creating medium risk due to potential uncertainty.

Analyst Insight

A smart investor would monitor subsequent filings from BIO-PATH HOLDINGS, INC. for the specific details and outcomes of the shareholder vote, as these will reveal the actual impact on the company's operations or capital structure.

Key Numbers

• $0.001 — Par value per share (This is the stated par value of BIO-PATH HOLDINGS, INC.'s common stock.)

Key Players & Entities

• BIO-PATH HOLDINGS, INC. (company) — the registrant filing the 8-K
• BPTH (company) — trading symbol for BIO-PATH HOLDINGS, INC.
• The Nasdaq Capital Market (company) — exchange where BPTH common stock is registered
• January 30, 2024 (date) — date of earliest event reported
• February 2, 2024 (date) — date the 8-K was filed
• $0.001 (dollar_amount) — par value per share of common stock

Forward-Looking Statements

• BIO-PATH HOLDINGS, INC. will disclose the results of the shareholder vote in a subsequent filing. (BIO-PATH HOLDINGS, INC.) — high confidence, target: 2024-03-31

FAQ

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital M

Filing Documents

• bpth-20240130x8k.htm (8-K) — 37KB
• 0001558370-24-000716.txt ( ) — 153KB
• bpth-20240130.xsd (EX-101.SCH) — 3KB
• bpth-20240130_lab.xml (EX-101.LAB) — 16KB
• bpth-20240130_pre.xml (EX-101.PRE) — 10KB
• bpth-20240130x8k_htm.xml (XML) — 5KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. As previously reported, Bio-Path Holdings, Inc. (the "Company") convened a special meeting (the "Special Meeting") of stockholders of the Company on January 22, 2024 at which a quorum was present. As reported on the Company's Current Report on Form 8-K filed on January 23, 2024, the Special Meeting was adjourned to allow the Company to solicit additional proxies in favor of an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's common stock, par value $0.001 per share, at a ratio of up to 1-for-50, to be determined by the Board ("Proposal One") . On January 30, 2024, the Company reconvened the Special Meeting. At the reconvened Special Meeting, t he sole item of business presented to stockholders for consideration was a vote on Proposal One, which was approved by the required vote. The final voting results for Proposal One are set forth below. Proposal One : For the approval of an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's common stock, par value $0.001 per share, at a ratio of up to 1-for-50, to be determined by the Board: Shares Voted "For" Shares Voted "Against" Shares Withheld Shares Abstained Broker Non-Votes 3,730,378.71 3,189,585.79 -- 42,153.00 --

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-PATH HOLDINGS, INC. Dated: February 2, 2024 By: /s/ Peter H. Nielsen Peter H. Nielsen President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR